These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10920575)

  • 1. Subjective sensation of heaviness in gout patients.
    Toda K
    Hiroshima J Med Sci; 2000 Jun; 49(2):101-3. PubMed ID: 10920575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.
    Riedel AA; Nelson M; Joseph-Ridge N; Wallace K; MacDonald P; Becker M
    J Rheumatol; 2004 Aug; 31(8):1575-81. PubMed ID: 15290738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
    de Klerk E; van der Heijde D; Landewé R; van der Tempel H; Urquhart J; van der Linden S
    J Rheumatol; 2003 Jan; 30(1):44-54. PubMed ID: 12508389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.
    de Klerk E; van der Heijde D; Landewé R; van der Tempel H; van der Linden S
    J Rheumatol; 2003 Nov; 30(11):2469-75. PubMed ID: 14677194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates in the management of gout.
    Keith MP; Gilliland WR
    Am J Med; 2007 Mar; 120(3):221-4. PubMed ID: 17349440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum urate levels and gout flares: analysis from managed care data.
    Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
    J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.
    Gast LF
    Clin Rheumatol; 1987 Mar; 6(1):70-3. PubMed ID: 3581700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute gout in hospitalized patients.
    Petersel D; Schlesinger N
    J Rheumatol; 2007 Jul; 34(7):1566-8. PubMed ID: 17610315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol-induced DRESS syndrome.
    Markel A
    Isr Med Assoc J; 2005 Oct; 7(10):656-60. PubMed ID: 16259349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of gout with alternate-day antihyperuricemic drugs (author's transl)].
    Nishizawa T; Nishida Y; Masuda T; Akaoka I
    Ryumachi; 1978 Mar; 18(2):104-11. PubMed ID: 663791
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gout as an unusual cause of pelvic pain].
    van den Berge M; Vrugt B; Holt C; Smit CJ; Hoogenberg K
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):151-4. PubMed ID: 16463619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.